Approved indications across the class span type 2 diabetes, chronic weight management for products such as Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024
By leveraging functional ingredients, rethinking product design, and aligning with changing consumer preferences, companies can position themselves as leaders in this emerging space.
Semaglutides Impact on Womens Weight Loss Women face unique challenges in weight management, from hormonal fluctuations to pregnancy and menopause, all of which can affect metabolism and weight
Because Bella is a compounded formula (not a long-term maintenance drug with established safety data), doctors tend to be cautious about indefinite use
Possible but the opioid-GLP-1 combination commonly causes severe constipation